Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on May 5, 2025
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
GlobeNewswire
·
May 5, 2025
Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months from date of diagnosis [95% CI; 17 …
Smith+Nephew stellt sein CORI™ Surgical System in chirurgischen Kliniken in Deutschland, Österreich und der Schweiz vor
GlobeNewswire
·
May 5, 2025
Die Roadshow „CORI on Tour“ zeigt die neuesten Fortschritte in der robotergestützten Chirurgie für Knie- und Hüftgelenkersatz Smith+Nephew (LSE:SN, NYSE:SNN), das globale Medizintechnikunternehmen, kündigt heute eine monatelange Roadshow durch …
NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1900 (NBTXR3) DANS LE CANCER DU PANCREAS
GlobeNewswire
·
May 5, 2025
Les résultats ont démontré un bon profil de tolérance, une faisabilité d’injection satisfaisante, ainsi que des signaux cliniques encourageants en matière d‘activité antitumorale chez des patients atteints d’un cancer du pancréas localement avancé ou à la …
Dr. Jacob Buinewicz Achieves Double Board Certification
GlobeNewswire
·
May 5, 2025
DOYLESTOWN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Just in time for Mental Health Awareness Month in May, Dr. Jacob Buinewicz is proud to announce that he has achieved a second board certification from the American Board of Psychiatry and Neurology. Dr. …
GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
GlobeNewswire
·
May 5, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 5 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions
GlobeNewswire
·
May 5, 2025
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based …
GENFIT to Present Latest ACLF Research at EASL Congress 2025
GlobeNewswire
·
May 5, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
GlobeNewswire
·
May 5, 2025
ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today a co-discovery alliance …
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
GlobeNewswire
·
May 5, 2025
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the …